RCM
GILD icon

Riverhead Capital Management’s Gilead Sciences GILD Stock Holding History

Riverhead Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$10.3M Buy
163,064
+35,850
+28% +$2.34M 0.38% 46
2019
Q2 		$8.6M Buy
127,214
+24,550
+24% +$1.62M 0.32% 66
2019
Q1 		$6.67M Buy
102,664
+3,550
+4% +$236K 0.27% 89
2018
Q4 		$6.2M Sell
99,114
-4,262
-4% -$298K 0.28% 81
2018
Q3 		$7.98M Sell
103,376
-8,586
-8% -$648K 0.29% 76
2018
Q2 		$7.93M Buy
111,962
+9,278
+9% +$655K 0.31% 74
2018
Q1 		$7.74M Buy
102,684
+5,100
+5% +$405K 0.33% 71
2017
Q4 		$6.99M Buy
97,584
+3,720
+4% +$282K 0.3% 82
2017
Q3 		$7.61M Sell
93,864
-18,101
-16% -$1.38M 0.36% 63
2017
Q2 		$7.92M Sell
111,965
-9,074
-7% -$604K 0.39% 48
2017
Q1 		$8.22M Sell
121,039
-16,799
-12% -$1.18M 0.45% 37
2016
Q4 		$9.87M Sell
137,838
-13,646
-9% -$1.01M 0.61% 27
2016
Q3 		$12M Buy
151,484
+137,228
+963% +$11.1M 0.77% 18
2016
Q2 		$418K Sell
14,256
-741,793
-98% -$65.8M 0.01% 653
2016
Q1 		$69.5M Buy
756,049
+345,518
+84% +$31.2M 0.98% 8
2015
Q4 		$41.5M Buy
410,531
+2,186
+0.5% +$227K 0.61% 28
2015
Q3 		$40.1M Sell
408,345
-42,104
-9% -$4.68M 0.63% 26
2015
Q2 		$52.7M Sell
450,449
-7,519
-2% -$822K 0.8% 19
2015
Q1 		$44.9M Sell
457,968
-40,669
-8% -$4.13M 0.68% 25
2014
Q4 		$47M Buy
498,637
+109,381
+28% +$11.3M 0.71% 24
2014
Q3 		$41.4M Buy
389,256
+162,000
+71% +$15.9M 0.71% 25
2014
Q2 		$18.8M Buy
227,256
+119,851
+112% +$9.33M 0.35% 79
2014
Q1 		$7.61M Buy
107,405
+6,772
+7% +$531K 0.17% 172
2013
Q4 		$7.56M Buy
100,633
+25,633
+34% +$1.78M 0.2% 151
2013
Q3 		$4.71M Hold
75,000
– – 0.15% 175
2013
Q2 		$3.85M Buy
+75,000
New +$3.91M 0.13% 199

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Riverhead Capital Management's GILD Position: Q3 2019 in Review

Riverhead Capital Management increased its Gilead Sciences (GILD) stake by 28% in Q3 2019, buying an estimated $2.34M and bringing the position to 163,064 shares worth $10.3M. The position accounts for 0.38% of the portfolio, ranked #46.

Riverhead Capital Management first reported a position in GILD in Q2 2013 and has held it in 26 quarters since. The position peaked at $69.5M in Q1 2016. 1,463 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

  • Riverhead Capital Management held 163,064 shares of Gilead Sciences worth $10.3M as of Q3 2019.
  • Riverhead Capital Management bought 35,850 Gilead Sciences shares in Q3 2019, an estimated $2.34M.
  • Gilead Sciences made up 0.38% of Riverhead Capital Management's portfolio in Q3 2019, its #46 holding.
  • Riverhead Capital Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 26 quarters since.
  • Riverhead Capital Management's Gilead Sciences position peaked at $69.5M in Q1 2016.
  • 1,463 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.